Viewing Study NCT00629967


Ignite Creation Date: 2025-12-25 @ 12:28 AM
Ignite Modification Date: 2026-01-01 @ 9:40 PM
Study NCT ID: NCT00629967
Status: COMPLETED
Last Update Posted: 2008-03-06
First Post: 2008-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients
Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module